Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...

SCIENCE: Trudeau Institute, Ampersand Biosciences producing tools for flu research with $1M grant SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...

The Amsterdam UMC has sued Ronald Plasterk and the biotech firm CureVac for failing to credit the hospital and its scientist, ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.

Small companies attempting to help solve a global crisis in drug-resistant infections with novel treatments are facing a wall ...

Attovia Therapeutics doses first participant in phase 1 study of ATTO-1310, its novel HLF anti-IL-31 ATTOBODY to treat chronic pruritus: Fremont, California Saturday, January 25, ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...